Cite
MLA Citation
Michael McFarlane et al.. “Clinical outcomes at 12 months and risk of inflammatory bowel disease in patients with an intermediate raised fecal calprotectin: a 'real-world' view.” BMJ open, vol. 6, no. 6, 2016, p. . http://access.bl.uk/ark:/81055/vdc_100134878325.0x00000d